CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 294 filers reported holding CANTEL MEDICAL CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $35,000 | -94.5% | 439 | -95.4% | 0.00% | -100.0% |
| Q1 2019 | $638,000 | -54.3% | 9,532 | -24.0% | 0.01% | -50.0% |
| Q1 2018 | $1,397,000 | +8.3% | 12,543 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $1,290,000 | -2.1% | 12,543 | -10.4% | 0.01% | 0.0% |
| Q3 2017 | $1,318,000 | +20.8% | 14,000 | 0.0% | 0.01% | +28.6% |
| Q2 2017 | $1,091,000 | -2.7% | 14,000 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $1,121,000 | -38.8% | 14,000 | -66.9% | 0.01% | +16.7% |
| Q4 2014 | $1,832,000 | +14.7% | 42,338 | -8.8% | 0.01% | +20.0% |
| Q3 2014 | $1,597,000 | -25.4% | 46,438 | -20.5% | 0.01% | -16.7% |
| Q2 2014 | $2,140,000 | -12.4% | 58,438 | -19.3% | 0.01% | -14.3% |
| Q1 2014 | $2,443,000 | -20.2% | 72,438 | -19.8% | 0.01% | -22.2% |
| Q4 2013 | $3,063,000 | -6.1% | 90,338 | -11.8% | 0.01% | -10.0% |
| Q3 2013 | $3,263,000 | +35.0% | 102,438 | +43.6% | 0.01% | +42.9% |
| Q2 2013 | $2,417,000 | – | 71,359 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
| Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
| Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
| Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
| Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
| Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
| EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
| FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |